Facente Consulting supported Gilead Sciences with statistical analysis relating to HIV incidence rates, assisting with the study design, analysis plan, and interpretation of study data for the PURPOSE trials–ultimately leading to the groundbreaking FDA approval of the twice-yearly PrEP medication Lenacapavir.
San Francisco AIDS Foundation asked Facente Consulting to develop a comprehensive evaluation plan to monitor potential changes in client outcomes following implementation of their new strategic plan.
Dr. Facente served as the project manager for the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA) for more than a decade, providing high-level project coordination and analytic support to researchers focused on HIV incidence estimation around the world.
Facente Consulting assisted the San Francisco Department of Public Health in planning for improved viral hepatitis surveillance and developing their first comprehensive viral hepatitis surveillance report in 11 years.
Facente Consulting is supporting The Center at the Sierra Health Foundation in understanding Syringe Services Program-led Medications for Addiction Treatment (MAT) in California.
Facente Consulting helped shape and execute an epidemiological analysis of patterns related to recency of HIV infection at the time of diagnosis in San Francisco, in relation to the COVID-19 pandemic.
LGBTQ Connection hired Facente Consulting to provide advanced statistical support for evaluation of their local intervention under the California Reducing Disparities Project, intended to reduce mental health disparities for young LGBTQ+ people in the Napa and Santa Rosa areas of California.
Facente Consulting helped San Francisco’s Jail Health Services develop infrastructure within their medical record system to do enhanced HCV-related panel management of people who are incarcerated, and regularly estimate their jail-based HCV cascade of care.
Facente Consulting conducted a program evaluation for CDC-funded syringe service programs working to scale up vaccine delivery capacity at their programs.
Facente Consulting collaborated with the San Francisco Department of Public Health and the Florida Department of Public Health to plan and implement institutes focused on improving capacity for HIV PrEP in Florida.
Facente Consulting collaborated with The Center at Sierra Health Foundation to improve access to Medications for Addiction Treatment (MAT) in California.
Facente Consulting was selected by End Hep C SF to design and lead a mixed-methods needs assessment to identify gaps in hepatitis C (HCV) testing and treatment in San Francisco jails, identify best practices for treatment and linkage, and develop a HCV care cascade for people currently or recently incarcerated.
The California Department of Public Health hired Facente Consulting to analyze and summarize nearly a decade of data from annual National HIV Behavioral Surveillance (NHBS) surveys conducted in San Diego.
Facente Consulting supported the County of San Diego in assessing readiness for harm reduction services in the southeast region of the county.
Facente Consulting worked with the San Francisco Department of Public Health’s Center for Learning and Innovation to support the design and implementation of Project INVEST (Innovations that Value Equity and Stength in Teams), a workforce retention evaluation initiative.
Facente Consulting served as the lead evaluator for a local LGBTQ+ mental health-focused impact evaluation that involved evaluation design, managing IRB approvals, overseeing data collection, and quantitative analysis.
Facente Consulting implemented an evaluation of Harm Reduction Michigan’s initiative to establish naloxone boxes as a form of overdose prevention.
Facente Consulting was hired during the formation of End Hep C SF to provide “backbone support” for this collective impact initiative, assist with strategic planning, and lead research and surveillance activities to monitor progress toward hepatitis C elimination.
Dr. Facente was a co-investigator on this two-year research study funded by the National Institute on Drug Abuse (NIDA), with the goal of better understanding the epidemiology of hepatitis C in three high-burden subpopulations in San Francisco.
To support San Francisco’s Tobacco-Free Project in analyzing local data to report during community engagement meeting presentations, Facente Consulting analyzed datasets from the California Health Interview Survey (CHIS) and the Healthy Stores Healthy Communities (HSHC) Survey.